Semon Wu

2.0k total citations · 1 hit paper
71 papers, 1.4k citations indexed

About

Semon Wu is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Semon Wu has authored 71 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Semon Wu's work include Adipokines, Inflammation, and Metabolic Diseases (21 papers), Genetic Associations and Epidemiology (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Semon Wu is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (21 papers), Genetic Associations and Epidemiology (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Semon Wu collaborates with scholars based in Taiwan and United States. Semon Wu's co-authors include Yu‐Lin Ko, Lung‐An Hsu, Ming‐Sheng Teng, Hsin‐Hua Chou, Yuchen Sun, Leay‐Kiaw Er, Chi‐Jen Chang, Jeng-Feng Lin, Ying‐Shiung Lee and Hsuan‐Li Huang and has published in prestigious journals such as Circulation, PLoS ONE and Scientific Reports.

In The Last Decade

Semon Wu

67 papers receiving 1.4k citations

Hit Papers

Triglyceride Glucose-Body Mass Index Is a Simple and Clin... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals
    2016 401 citations Leay‐Kiaw Er, Semon Wu et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Semon Wu Taiwan 20 420 409 324 319 268 71 1.4k
Andromachi Vryonidou Greece 22 805 1.9× 293 0.7× 283 0.9× 292 0.9× 339 1.3× 67 1.9k
Bernhard Böhm Germany 22 427 1.0× 304 0.7× 308 1.0× 351 1.1× 338 1.3× 68 1.7k
Derun Taner Ertuğrul Türkiye 26 439 1.0× 237 0.6× 229 0.7× 315 1.0× 397 1.5× 95 1.7k
Arnon Blum Israel 24 213 0.5× 323 0.8× 439 1.4× 303 0.9× 426 1.6× 62 1.8k
Ronen Durst Israel 21 219 0.5× 361 0.9× 494 1.5× 316 1.0× 592 2.2× 87 1.8k
Jinrui Cui United States 23 394 0.9× 374 0.9× 215 0.7× 423 1.3× 229 0.9× 45 1.6k
Ana Megía Spain 25 436 1.0× 506 1.2× 255 0.8× 528 1.7× 326 1.2× 73 1.9k
Flavia Agata Cimini Italy 20 353 0.8× 614 1.5× 139 0.4× 287 0.9× 210 0.8× 55 1.3k
Shirley Nakhla Australia 20 559 1.3× 201 0.5× 352 1.1× 276 0.9× 389 1.5× 27 1.5k
Stella Bernardi Italy 27 846 2.0× 351 0.9× 446 1.4× 595 1.9× 621 2.3× 91 2.1k

Countries citing papers authored by Semon Wu

Since Specialization
Citations

This map shows the geographic impact of Semon Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semon Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semon Wu more than expected).

Fields of papers citing papers by Semon Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Semon Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semon Wu. The network helps show where Semon Wu may publish in the future.

Co-authorship network of co-authors of Semon Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Semon Wu. A scholar is included among the top collaborators of Semon Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Semon Wu. Semon Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Lung‐An, et al.. (2025). Circulating resistin levels and mutation burden of the RETN gene variants predict long-term mortality in a Taiwanese population. Scientific Reports. 15(1). 564–564. 1 indexed citations
2.
3.
Chou, Hsin‐Hua, Ming‐Sheng Teng, Fu‐Tien Chiang, et al.. (2024). Circulating YKL-40 levels but not CHI3L1 or TRIB1 gene variants predict long-term outcomes in patients with angiographically confirmed multivessel coronary artery disease. Scientific Reports. 14(1). 29416–29416.
4.
Ko, Yu‐Lin, Wei‐Chih Su, Chia‐Chi Wang, et al.. (2024). SLC10A1 rs2296651 variant (S267F mutation) predicts biochemical traits, hepatitis B virus infection susceptibility and the risk of gallstone disease. Molecular Genetics and Genomics. 299(1). 62–62.
5.
Teng, Ming‐Sheng, Kun‐Huei Yeh, Lung‐An Hsu, et al.. (2023). Differential Effects of ABCG5/G8 Gene Region Variants on Lipid Profile, Blood Pressure Status, and Gallstone Disease History in Taiwan. Genes. 14(3). 754–754. 4 indexed citations
6.
Yeh, Kun‐Huei, Lung‐An Hsu, Fu‐Tien Chiang, et al.. (2022). Circulating serum amyloid A levels but not SAA1 variants predict long-term outcomes of angiographically confirmed coronary artery disease. Tzu Chi Medical Journal. 34(4). 423–433.
7.
Chou, Hsin‐Hua, Ming‐Sheng Teng, Lung‐An Hsu, et al.. (2021). Circulating chemerin level is associated with metabolic, biochemical and haematological parameters—A population‐based study. Clinical Endocrinology. 94(6). 927–939. 14 indexed citations
8.
Hsu, Lung‐An, Hsin‐Hua Chou, Ming‐Sheng Teng, Semon Wu, & Yu‐Lin Ko. (2021). Circulating chemerin levels are determined through circulating platelet counts in nondiabetic Taiwanese people: A bidirectional Mendelian randomization study. Atherosclerosis. 320. 61–69. 11 indexed citations
9.
Wu, Semon, Wen‐Cheng Huang, Yu‐Heng Lai, et al.. (2020). Establishment of an Immunocompetent Metastasis Rat Model with Hepatocyte Cancer Stem Cells. Cancers. 12(12). 3721–3721. 2 indexed citations
10.
11.
Lin, Jeng-Feng, Semon Wu, Jyh‐Ming Jimmy Juang, et al.. (2016). IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease. Atherosclerosis. 257. 71–77. 11 indexed citations
12.
13.
Lin, Jeng-Feng, et al.. (2014). Growth-Differentiation Factor-15 and Major Cardiac Events. The American Journal of the Medical Sciences. 347(4). 305–311. 32 indexed citations
14.
Chen, Mao‐Liang, Semon Wu, Tzung‐Chieh Tsai, Lu‐Kai Wang, & Fu‐Ming Tsai. (2013). Regulation of macrophage immune responses by antipsychotic drugs. Immunopharmacology and Immunotoxicology. 35(5). 573–580. 43 indexed citations
15.
Huang, Hsuan‐Li, Semon Wu, Lung‐An Hsu, et al.. (2013). Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity. BMC Medical Genetics. 14(1). 30–30. 13 indexed citations
16.
Ko, Yu‐Lin, Tsu‐Shiu Hsu, Chi‐Jen Chang, et al.. (2011). Angiotensin-I Converting Enzyme Gene Polymorphisms and the Risk of Venous Thromboembolism in an Ethnically Chinese Population Living in Taiwan. Zhōnghuá mínguó xīnzàngxué huì zázhì. 27(4). 252–258. 1 indexed citations
17.
Hsu, Lung‐An, Ming‐Sheng Teng, Yu‐Lin Ko, et al.. (2009). The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan. Clinical Chemistry and Laboratory Medicine (CCLM). 47(2). 154–8. 35 indexed citations
18.
Chou, Hsin‐Hua, et al.. (2009). Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese. Metabolism. 59(6). 824–830. 23 indexed citations
19.
Hsu, Lung‐An, et al.. (2008). Apolipoprotein A5 gene −1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan. Clinical Chemistry and Laboratory Medicine (CCLM). 46(12). 1714–9. 27 indexed citations
20.
Hsu, Lung‐An, Yu‐Lin Ko, Chi‐Jen Chang, et al.. (2005). Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis. 185(1). 143–149. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andromachi Vryonidou Breakdown of academic impact, for papers by Bernhard Böhm Breakdown of academic impact, for papers by Derun Taner Ertuğrul Breakdown of academic impact, for papers by Arnon Blum Breakdown of academic impact, for papers by Ronen Durst Breakdown of academic impact, for papers by Jinrui Cui Breakdown of academic impact, for papers by Ana Megía Breakdown of academic impact, for papers by Flavia Agata Cimini Breakdown of academic impact, for papers by Shirley Nakhla Breakdown of academic impact, for papers by Stella Bernardi
Rankless by CCL
2026